Table 2.
Characteristics | n | 3-year OS | P | 3-year DFS | P | 3-year LRC | P |
---|---|---|---|---|---|---|---|
% | % | % | |||||
Age, years | 0.114 | 0.207 | 0.846 | ||||
<70 | 25 | 90 | 66 | 70 | |||
≥70 | 24 | 73 | 47 | 73 | |||
Histological type | 0.591 | 0.037 | 0.028 | ||||
SCC | 42 | 88 | 66 | 77 | |||
Others | 7 | 50 | 19 | 38 | |||
FIGO stage | 0.687 | 0.026 | 0.019 | ||||
I/II | 39 | 83 | 63 | 77 | |||
III/IV | 10 | 83 | 40 | 48 | |||
Clinical N stage | 0.395 | 0.100 | 0.023 | ||||
N0 | 34 | 84 | 65 | 80 | |||
N1 | 15 | 82 | 47 | 53 | |||
size, cm | 0.477 | 0.582 | 0.117 | ||||
<4 | 31 | 82 | 59 | 77 | |||
≥4 | 18 | 85 | 58 | 62 | |||
Involvement of lower 1/3 | 0.976 | 0.831 | 0.280 | ||||
NO | 30 | 85 | 59 | 77 | |||
YES | 19 | 81 | 58 | 62 | |||
Chemotherapy | 0.268 | 0.657 | 0.764 | ||||
NO | 43 | 85 | 58 | 72 | |||
Yes | 6 | 67 | 63 | 63 | |||
Brachytherapy | 0.555 | 0.258 | 0.075 | ||||
YES | 41 | 84 | 61 | 76 | |||
NO | 8 | 67 | 50 | 50 |
OS = overall survival rate, DFS = disease-free survival rate, LRC = loco-regional control rate, SCC = squamous cell carcinoma, FIGO = Federation of Gynecology and Obstetrics.